• to the main navigation
  • to the search
  • to the content
  • to the service navigation
informedhealth.org - HomepageHomepageInformedHealth.org - independent, evidence-based
  • Contact us
  • Newsletter
  • Deutsch
  • Homepage
  • Topic areas
  • Topics: A to Z list
  • About us
Search

Search results for ""hiv infection""

123backnext
  • Overview

    Emtricitabine / rilpivirine / tenofovir alafenamide ...

    The fixed combination of emtricitabine / rilpivirine / tenofovir alafenamide (trade name: Odefsey) has been approved in Germany since June 2016 for the treatment of type 1 HIV in adults and children aged 12 and over. more...

  • Learn more

    Dolutegravir for first-line treatment of HIV in adults ...

    Dolutegravir for first-line treatment of HIV in adults. In the spring of 2014 the Institute for Quality and Efficiency in Health Care (IQWiG, Germany) assessed which advantages and disadvantages dolutegravir has compared with previous standard therapies in people who are having initial treatment for HIV. more...

  • Learn more

    Fixed-dose combination of bictegravir / emtricitabine ...

    Frequency of AIDS-related illnesses: A weakened immune system caused by an HIV infection makes a number of illnesses such as certain bacterial, viral or fungal infections more likely. The success of a particular treatment can be measured by whether these illnesses are less common. In the study, AIDS broke out in about 8 out of 1000 people ... more...

  • Overview

    Fixed-dose combination of bictegravir / emtricitabine ...

    Without treatment, the immune system is weakened so much by the HIV infection that serious diseases arise. This stage is called “AIDS” (acquired immunodeficiency syndrome). Although the currently available medications can't cure HIV, they can prevent immunodeficiency permanently. more...

  • Learn more

    Vaginal yeast infections (thrush): What helps? - Vaginal ...

    Yeast infections are also considered to be complicated if they’re caused by a weakened immune system, for instance due to an HIV infection. When treating complicated vaginal yeast infections, an initial treatment is typically followed by maintenance treatment. In the initial phase of treatment, creams or suppositories are used for 1 to 2 ... more...

  • Overview

    Emtricitabine / tenofovir alafenamide (Descovy) for HIV ...

    The fixed combination emtricitabine / tenofovir alafenamide (trade name: Descovy) has been approved in Germany since April 2016 for the treatment of human immunodeficiency virus (HIV) type 1 infection in adults and adolescents over 12 years of age. more...

  • Learn more

    Ledipasvir / sofosbuvir (Harvoni) for hepatitis C ...

    The patients did not also have an HIV infection. For this group, IQWiG performed a historical comparison with data from a total of nine studies. Five of these studies looked into treatment with ledipasvir / sofosbuvir and the other four examined the triple therapy with peginterferon alfa, ribavirin, and boceprevir or telaprevir. more...

  • Research summaries

    Oral thrush: Prevention during cancer treatment - Oral ...

    Oral thrush is a common side effect of cancer treatment. Find out which antifungal medications can prevent it. more...

  • Treatments and diagnostic tests

    Personalized medicine

    Personalized medicine is based on these biological markers, also known as "biomarkers." Many biomarkers were only discovered in the last few years. So, nowadays, personalized medicine actually means using a specific combination of tests and treatments. Depending on the test results, a specific treatment will be recommended. Example: Malignant ... more...

  • Learn more

    Fixed-dose combination of bictegravir / emtricitabine ...

    Fixed-dose combination of bictegravir / emtricitabine / tenofovir alafenamide (Biktarvy) as a subsequent treatment of HIV. In 2018, the Institute for Quality and Efficiency in Health Care (IQWiG, Germany) wanted to find out whether the fixed-dose combination of bictegravir / emtricitabine / tenofovir alafenamide (trade name: Biktarvy) has any ... more...

123backnext
Updated September 24th 2019 September 24th 2019
Created September 16th 2013
How we work
Published by the Institute for Quality and Efficiency in Health Care (IQWiG, Germany)
About the authors and the institute
IQWIG - Institute for Quality and Efficiency in Health Care
About us
  • IQWiG
  • InformedHealth.org
  • How our content is structured
  • Our approach
  • FAQs
  • Legal notice
Service
  • Contact us
  • Data protection policy
  • Newsletter
  • Using news feeds
  • Glossary
  • German Homepage
This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information:
verify here.